A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes.
about
An independent component analysis confounding factor correction framework for identifying broad impact expression quantitative trait lociNecdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc.GNL3 and SKA3 are novel prostate cancer metastasis susceptibility genes.Mapping Complex Traits in a Diversity Outbred F1 Mouse Population Identifies Germline Modifiers of Metastasis in Human Prostate Cancer.Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer."Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.Correction: A Systems Genetics Approach Identifies CXCL14, ITGAX, and LPCAT2 as Novel Aggressive Prostate Cancer Susceptibility Genes.Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance.Stromal factors involved in human prostate cancer development, progression and castration resistance.CXCL14 and NOS1 expression in specimens from patients with stage I-IIIA nonsmall cell lung cancer after curative resection.Global Gene Expression Analysis in an in vitro Fibroblast Model of Idiopathic Pulmonary Fibrosis Reveals Potential Role for CXCL14/CXCR4.Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods.Prognostic Value of RNASEH2A-, CDK1-, and CD151-Related Pathway Gene Profiling for Kidney Cancers.Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.Prostate cancer susceptibility gene HIST1H1A is a modulator of androgen receptor signaling and epithelial to mesenchymal transition.
P2860
Q33739437-88B0B470-FE56-4B42-96E4-8FE7796BE99EQ36544627-99FAE1F1-18B6-403D-9688-1DB4A17A6C5AQ38830853-AA060F4E-D66F-4963-9085-E30278548994Q39132258-B6E8A635-1900-4F53-9D1F-CA124980C9E0Q41512848-0F714880-38F8-495C-BEFA-893983AA8DABQ42366169-11DAB8FC-2611-4492-8909-DA2B5E113E44Q42578326-F74944CF-7772-4314-A315-081CA7DA2756Q49865078-4534CC2B-1F3D-4430-8043-5A935A1EEE9BQ51360042-61991F86-61DA-4AEF-8EE2-5001DA50493CQ51735301-19FB8A09-165D-4D22-8AFA-819DC717F302Q52673165-7FD4F9ED-0A4F-4D05-BE12-59EC22ABA5BAQ53176174-5109BF26-03AD-40FA-ACB4-6A16DDF0FEEBQ54977830-F6FF5CF6-D768-4A86-BC68-003DD0CE995FQ55265680-DCEFD508-CFCD-4509-8732-C9C055E805FAQ55449498-149A2B2C-6CD7-45E2-BE58-7D1F0E9220CB
P2860
A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A systems genetics approach id ...... e cancer susceptibility genes.
@ast
A systems genetics approach id ...... e cancer susceptibility genes.
@en
A systems genetics approach id ...... e cancer susceptibility genes.
@nl
type
label
A systems genetics approach id ...... e cancer susceptibility genes.
@ast
A systems genetics approach id ...... e cancer susceptibility genes.
@en
A systems genetics approach id ...... e cancer susceptibility genes.
@nl
prefLabel
A systems genetics approach id ...... e cancer susceptibility genes.
@ast
A systems genetics approach id ...... e cancer susceptibility genes.
@en
A systems genetics approach id ...... e cancer susceptibility genes.
@nl
P2093
P2860
P1433
P1476
A systems genetics approach id ...... te cancer susceptibility genes
@en
P2093
Abdel Elkahloun
Alfredo A Molinolo
Jonathan Andreas
Kendra A Williams
Minnkyong Lee
Nigel P S Crawford
Peter Chines
Settara Chandrasekharappa
Shashank J Patel
Suiyuan Zhang
P2860
P304
P356
10.1371/JOURNAL.PGEN.1004809
P577
2014-11-20T00:00:00Z